Insight into pharmaceutical deals and trends

In Vivo Outlook 2021 Report

16 Jun 2022

The highly anticipated Outlook 2022 report from Informa Pharma Intelligence is coming soon. Reach the thousands of senior decision makers who eagerly await this pharma industry ranking and review for the year ahead, with sponsorship opportunities that align your brand with our trusted information. 

Topic deal-trends biopharmaceutical business-strategies

How To Obtain Effective Relief When A Global Pandemic Disrupts Your Supply Chain

By Dorothee Schramm and Katie von der Weid 27 Nov 2020

The COVID-19 pandemic is disrupting global supply chains and companies need effective tools to manage the related contract disputes. Sidley Austin partner Dorothee Schramm and senior associate Katie von der Weid, both specialized in international commercial disputes, provide tips to help companies manage the situation.

Topic Coronavirus business-strategies deal-trends

Coherus Is Confident After US Ranibizumab Filing

By Aidan Fry 27 Nov 2020

Having seen its development partner Bioeq file with the FDA in December last year, Coherus is confident that it will be a leader in the US biosimilar ranibizumab market targeting Lucentis.

Topic biosimilars deal-trends

Biocon Biologics Gets True North Investment

By Vibha Ravi 27 Nov 2020

Private equity group True North continues to back the Biocon group and is picking up a minority stake in Biocon Biologics in a deal that values the subsidiary at $3bn. Separately, another subsidiary, Biocon Biosphere, has also been set up as part of efforts to unlock the full potential of the business.

Topic deal-trends strategy

Pfizer Reports 80% Biosimilars Growth In Q3

By Akriti Seth 17 Nov 2020

Pfizer has reported 80% growth in its global biosimilars business for the third quarter of 2020, on the back of recent oncology launches. Though the company’s sterile injectables saw a slight drop in business, Pfizer’s biopharma business saw 4% growth.

Topic Coronavirus biosimilars deal-trends

2020’s Most Significant Cancer Deals

21 Oct 2020

Gain insights into the oncology deals making headlines with exclusive reporting and analysis from Scrip. Explore a snapshot view of the year’s biggest oncology deals so far, in a convenient infographic and go deeper into two major cancer deals that occurred in September with your free article pack.    

Topic cancer deal-trends

Gene Therapy eBook

21 Aug 2020

Keep up with advances in the critically important, emerging area of gene therapy. This transformative new category of medicines has the potential to treat more diseases – including complex and rare diseases – with longer-lasting effects than traditional medicines.

Topic research deal-trends

In Vivo Deal Making Article Pack

15 Apr 2020

Gain a view into the market gaps, opportunities, and trends in biopharma with a look at deal-making from In Vivo. Examine how deal-making has impacted the industry and shifted market dynamics and learn how you can use knowledge of these trends to inform your own strategies.

Topic M A deal-trends

Sun Finds US ‘Challenging’

By Penelope MacRae 17 Feb 2020

Sun Pharma’s Indian domestic operations posted strong sales in the third quarter, but this was not enough to prevent the company from reporting a 26% tumble in consolidated net profit in the face of a “challenging” US generics market and slow approvals for complex products.

Topic deal-trends